AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (March 12, 2008). doi:10.1152/ajprenal.00458.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/5/F1094    most recent
00458.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Pearse, D. D.
Right arrow Articles by Jaimes, E. A
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pearse, D. D.
Right arrow Articles by Jaimes, E. A
Submitted on October 4, 2007
Accepted on March 11, 2008

Angiotensin II Increases the Expression of the Transcription Factor ETS-1 in Mesangial Cells

Damien D. Pearse1, Run-Xia Tian1, Jessica Nigro2, Julian B. Iorgulescu1, Leopold Puzis3, and Edgar A Jaimes4*

1 University of Miami School of Medicine, Miami, Florida, United States
2 VA Medical Center, Miami, Florida, United States
3 University of Miami School of Medicine, Miami, Florida, United States; Miami, Florida, United States
4 University of Miami School of Medicine, Miami, Florida, United States; VA Medical Center, Miami, Florida, United States

* To whom correspondence should be addressed. E-mail: edgar.jaimes2{at}med.va.gov.

Maladaptive activation of the renin angiotensin system (RAS) has been shown to play a critical role in the pathogenesis of chronic kidney disease. Reactive oxygen species (ROS) are critical signals for many of the non-hemodynamic effects of Angiotensin II (Ang II). We have demonstrated that Ang II increases mesangial and cortical COX-2 expression and activity via NADPH oxidase derived ROS. The transcription factor ETS-1 has been identified as a critical regulator of growth related responses and inflammation. The current studies were designed to determine: 1) whether Ang II induces ETS-1 expression in vitro in cultured rat mesangial cells (MC) and in vivo in rats infused with Ang II and 2) To determine if ROS and COX-2 are mediators of ETS-1 induction in response to Ang II. MC stimulated with Ang II (10-7 M) exhibited a significant increase in ETS-1 expression that was prevented by the AT1 receptor blocker candesartan. NADPH oxidase inhibition with DPI or apocynin also prevented ETS-1 induction, establishing the role of ROS as mediators of ETS-1 expression in response to Ang II. COX-2 inhibition prevented ETS-1 expression in response to Ang II suggesting that COX-2 is required for ETS-1 induction. By utilizing siRNAs against ETS-1 we have also determined that ETS-1 is required to induce the production of fibronectin in response to Ang II. Furthermore, rats infused with Ang II manifested increased glomerular expression of ETS-1. These studies unveil novel pathways that may play an important role in the pathogenesis of renal injury when RAS is activated.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.